GEMINUS THERAPEUTICS
Geminus Therapeutics is developing best-in-class Artemisinin (ART714) for treating leukemia.
GEMINUS THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Address:
Baltimore, Maryland, United States
Country:
United States
Status:
Active
Total Funding:
150 K USD
Investors List
Maryland Innovation Initiative (MII)
Maryland Innovation Initiative (MII) investment in Grant - Geminus Therapeutics
More informations about "Geminus Therapeutics"
Geminus Therapeutics Company Profile 2024: Valuation, Funding ...
Geminus Therapeutics was founded in 2020. Where is Geminus Therapeutics headquartered? Geminus Therapeutics is headquartered in Baltimore, MD. What industry is Geminus …See details»
Geminus Therapeutics - Funding, Financials, Valuation & Investors
Geminus Therapeutics is developing best-in-class Artemisinin (ART714) for treating leukemia. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ...See details»
Geminus Therapeutics LLC - Drug pipelines, Patents, Clinical trials ...
Jun 11, 2024 Explore Geminus Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, . Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for …See details»
Geminus Therapeutics - Products, Competitors, Financials, …
About Geminus Therapeutics. Geminus Therapeutics operates as a drug delivery company. It develops artemisinin (ART714) for treating leukemia. The company was founded in 2020 and …See details»
A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent …
BTM, CC, and MR are founders of Geminus Therapeutics LLC, serve on its Board of Directors and hold equity. Under a license agreement between Geminus Therapeutics LLC and the …See details»
Evaluation of Clinical Pharmacy Services for Phase 1 Clinical Trials
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock Locked padlock icon ... Dr Rudek is a founder of Geminus …See details»
Geminus Therapeutics - Crunchbase
Organization. Geminus Therapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. …See details»
Geminus Therapeutics Stock Price, Funding, Valuation, Revenue ...
See Geminus Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on Geminus Therapeutics's post-money valuation and revenue.See details»
Gemini Therapeutics and Disc Medicine Announce Merger …
Aug 10, 2022 Gemini Therapeutics, Inc. Brian Piekos Gemini Therapeutics, Inc. (617) 401-4400 IR@geminitherapeutics.com Disc Medicine, Inc. Peg Rusconi (Media) Verge Scientific …See details»
TEDCO’s Maryland Innovation Initiative Advances Innovative …
Nov 22, 2021 Geminus Therapeutics, located in Baltimore, is a University of Maryland, Baltimore spinout, developing best-in-class Artemisinin (ART714) for treating leukemia. Geothermal …See details»
Gemini Therapeutics Announces Corporate Restructuring to …
Oct 5, 2021 Therefore, we are shifting Gemini’s focus from a research and development organization to exclusively become a development-stage company. Gemini will concentrate its …See details»
Disc Medicine
Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders.See details»
Bitopertin (GlyT1 Inhibitor) - Disc Medicine
Erythropoietic porphyrias comprise three subtypes: Erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLPP), and Congenital Erythropoietic Porphyria (CEP)Erythropoietic …See details»
Grant - Geminus Therapeutics - 2021-11-22 - Crunchbase
Geminus Therapeutics raised $150000 on 2021-11-22 in Grant. Start Free Trial . Chrome ExtensionSee details»
Gemini Therapeutics Provides Corporate Update | Business Wire
Feb 28, 2022 Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically-defined age-rel. Gemini …See details»
PTC Therapeutics Enters into a Global License and Collaboration ...
4 hours ago "PTC518 is the leading oral disease-modifying therapy in development for Huntington's disease and the economics of this agreement are consistent with the promise of …See details»
Gemini Therapeutics Announces Initial Data From Its Ongoing …
Jun 22, 2021 Gemini Therapeutics is a clinical stage precision medicine company developing novel therapeutic compounds to treat genetically defined age-related macular degeneration …See details»
PTC Therapeutics Enters into a Global License and Collaboration ...
3 hours ago About PTC Therapeutics, Inc. PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that …See details»
PTC Therapeutics signs up to $2.9 billion licensing deal with ... - MSN
(Reuters) - PTC Therapeutics has signed an up to $2.9 billion licensing deal with Novartis AG for the U.S. company's experimental drug for a rare neurological disorder, sending its shares up …See details»
Geminus - Crunchbase Company Profile & Funding
Contact Email info@geminus.ai Phone Number 603-369-9890 Developer of an artificial intelligence platform for empowering engineers, industrial operators and machines to make …See details»